News
A three-drug combination worked better than any of them alone in treating ALS caused by mutations in the SOD1 gene, per a new ...
The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...
The guitarist, who also played in the Black Hollies, has also released a solo album recorded shortly before the diagnosis ...
Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...
Ferrer’s R&D work focuses on neurological and pulmonary diseases, and the Spanish pharma has bought into ALS assets in the ...
Advocates for patients with amyotrophic lateral sclerosis — a fatal condition known as Lou Gehrig’s disease — urged lawmakers ...
Coya Therapeutics sees success in early COYA-302 FTD trial, aims for Phase 2b in H2 2025 and ALS filing in Q2 2025. Read why ...
A protein was created where TDP-43 was fused to the SUMO2 protein and these fusion proteins were expressed in cells with or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results